ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Two medium-sized Indian pharmaceutical companies, Strides Arcolab and Shasun Pharmaceuticals, will merge to create an entity with annual sales of about $615 million. With headquarters in Chennai on the southeast coast of India, Shasun is a producer of generic formulations and active pharmaceutical ingredients that also provides contract research and manufacturing services. The firm employs 1,800. Strides, also a producer of generics, has headquarters in Bangalore and employs more than 1,500 people.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X